Lactulose

Lactulose is a man-made disaccharide, built from one unit of galactose joined to one of fructose, that is produced by chemically rearranging lactose, the sugar of milk ^[1]. Unlike ordinary dietary sugars it is not broken down or absorbed in the small intestine, so it travels intact to the colon, and this single property is the basis for both of its main medical uses ^[1][2]. It was first synthesized in the late 1920s and entered clinical practice in the 1950s, and it now appears on the World Health Organization's list of essential medicines ^[1][3].

As an osmotic laxative, lactulose draws water into the bowel and softens the stool, which makes it useful for chronic constipation across all age groups, although its effect is gradual rather than immediate ^[1]. Its second major use is in hepatic encephalopathy, the impaired brain function that can develop in advanced liver disease; here a large body of randomized trial evidence, summarized in systematic reviews, supports non-absorbable disaccharides such as lactulose for both treating and preventing episodes, with associated reductions in serious complications and mortality ^[2].

Once in the colon, lactulose is fermented by resident bacteria, and because this fermentation encourages the growth of beneficial groups such as bifidobacteria and lactobacilli, the compound is also regarded as a prebiotic; studies note that these effects on the microbiome vary from person to person and with the amount taken ^[1][3]. Lactulose is generally well tolerated, the most common complaints being gas, bloating, and abdominal cramps, and excessive use can lead to diarrhea and disturbances of fluid and electrolytes ^[1]. It is available as a syrup and is sold on prescription in some countries and over the counter in others ^[1].

Lactulose is available by prescription and is quite safe because almost none of it is absorbed. The main downsides are gas, bloating, and belly cramps, especially when you start, and too much causes diarrhea that can throw off fluids and electrolytes. People on a strict galactose-free diet should avoid it since it contains galactose, and those with diabetes should know it has a small sugar content. It is not an instant fix for constipation; it can take a day or two to work. In hepatic encephalopathy the dose is tuned to produce two or three soft stools a day.

Lactulose is not absorbed, so it does not compete for enzymes or transporters, and its interactions are all about whether colonic bacteria can still ferment it. That fermentation is the entire mechanism in hepatic encephalopathy: acidifying the colon traps ammonia as ammonium, which crosses the gut wall poorly.

Non-absorbable antacids in large doses raise colonic pH and blunt that acidification. Human and animal work with an implanted colonic electrode found the desired pH drop reduced when they were given together. Broad-spectrum and non-absorbed antibiotics, neomycin in particular, were long thought to remove the bacteria that degrade lactulose and so undercut it, though the clinical picture is genuinely mixed and some series found lactulose with neomycin more effective than either alone.

Beyond that, other laxatives make the stool endpoint impossible to read, which matters because titration in encephalopathy is guided by counting bowel movements. Systemic drug interactions are simply not a feature of this drug.

Checking a whole stack? Run it through interactions + stacks.

Lactulose was first synthesized in 1929 by Montgomery and Hudson, who prepared the disaccharide from lactose, but its medical significance emerged decades later. In the 1950s the Austrian pediatrician F. Petuely identified it as a bifidus factor that promoted beneficial gut flora in infants, drawing early attention to its prebiotic character. Its role as an osmotic laxative for chronic constipation was established through the 1960s, and in 1966 the physician Bircher and colleagues reported its striking benefit in hepatic encephalopathy, a use that transformed the management of that condition. Because humans lack an enzyme to digest it, lactulose reaches the colon intact, where fermentation and acidification lower ammonia absorption. It has since become a mainstay in hepatology and gastroenterology and is included on the World Health Organization's List of Essential Medicines.

Lactulose is regarded as a dependable and time-tested medicine, valued for treating two very different problems with a single elegant mechanism. In hepatic encephalopathy it is a first-line therapy; meta-analyses of randomized trials associate it with reduced mortality and substantially lower rates of recurrent overt encephalopathy, a genuinely meaningful benefit in liver disease. As an osmotic laxative it offers gentle, predictable relief that is considered suitable even for children and during pregnancy. An appealing bonus is its prebiotic effect, since colonic bacteria ferment it into short-chain acids that nourish beneficial flora. Its main drawbacks are practical rather than serious; bloating, flatulence, and a sweet taste can limit tolerability, and its onset is gradual. Overall it remains a trusted, essential-medicine-listed staple with a favorable safety record.